Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk
Abstract Background Hepatocellular carcinoma (HCC) remains highly lethal globally, with complex pathogenic mechanisms. This study employs Mendelian randomization (MR) to investigate causal relationships between immune cells, serum metabolites, and HCC risk. Methods A two-sample Mendelian randomizati...
Saved in:
| Main Authors: | Wei Shen, Yuanying Zeng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03037-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integration of single-cell sequencing and mendelian randomization reveals novel causal pathways between monocytes and hepatocellular carcinoma
by: Jiang Yu, et al.
Published: (2025-04-01) -
Mutual causal effects between immune cells and hepatocellular carcinoma: a Mendelian randomization study
by: Zheng Wang, et al.
Published: (2025-01-01) -
Decoding the epigenetic-immune nexus in hepatocellular carcinoma: a Mendelian randomization study reveals BTN3A2, S100A12 and TRIM27 as white blood cell regulators
by: Yang Qiu, et al.
Published: (2025-08-01) -
The impact of metabolic syndrome on hepatocellular carcinoma: a mendelian randomization study
by: Chendong Yuan, et al.
Published: (2025-01-01) -
Mendelian randomization analysis of inflammatory biomarkers and hepatocellular carcinoma risk: genetic causality and single-cell transcriptomics
by: GuangXin Shao, et al.
Published: (2025-08-01)